While the American Academy of Dermatology does not recommend the use of antihistamines for the management of atopic dermatitis (AD), they are often used to treat AD-associated pruritus. In a recent study published in the Journal of the American Academy of Dermatology, researchers investigated trends in prescriptions for sedating and non-sedating antihistamines for AD.

FDA Alerts

FDA Alerts
Thursday, November 30, 2017
The FDA has approved the relabeling of an over-the-counter cream for treatment of eczema.
FDA Alerts
Monday, November 20, 2017
The FDA has expanded the approval of a dermal spray label for the treatment of atopic dermatitis.
FDA Alerts
Tuesday, March 28, 2017
The FDA has approved Regeneron Pharmaceuticals Inc and Sanofi SA's dupilumab (Dupixent) for treatment of moderate to severe atopic dermatitis.
FDA Alerts
Monday, April 25, 2016
The FDA accepted Anacor Pharmaceuticals, Inc’s New Drug Application seeking approval of crisaborole topical ointment, 2%, a novel nonsteroidal topical anti-inflammatory phosphodiesterase-4 (PDE-4) inhibitor in development for the potential treatment of mild to moderate atopic dermatitis.

NEA Approved Content

NEA Approved Content
Thursday, June 23, 2016
This approach allows patients to receive personalized care from a variety of physicians and health care related professionals to meet their individual needs concerning many issues that patients with atopic dermatitis routinely face.  
NEA Approved Content
Tuesday, May 24, 2016
Posters included recent research covering a variety of aspects of atopic dermatitis.  
NEA Approved Content
Thursday, April 14, 2016
An 18-year-old female presented with skin lesions across her entire body. She complained of itchy, red skin patches with no known triggers. The flaking of her skin and nasal allergies were also worsening.
NEA Approved Content
Wednesday, February 17, 2016
This article highlights several posters presented on eczema at The Winter Clinical Dermatology Conference-Hawaii last month. 

News

News
Monday, January 8, 2018
After preliminary evidence suggested its beneficial effects, the FDA granted Breakthrough Therapy Designation for adult patients with moderate to severe atopic dermatitis.
News
Sunday, December 17, 2017
Contact with aeroallergens including house dust mites, pollen, and animal dander can lead to atopic dermatitis in some individuals. In a recent study, researchers assessed the diagnostic abilities of a certain tool vs skin prick testing in diagnosing atopic dermatitis.
News
Friday, December 15, 2017
In a recent study, researchers evaluated the impact of skin pain, along with itch severity, on quality of life in patients with atopic dermatitis.
News
Wednesday, December 6, 2017
Atopic dermatitis and hand eczema commonly co-occur. However, the exact estimation of their association is currently unknown. Researchers aimed to explore this further in a recent study.

Research in Review

Research in Review
Wednesday, December 27, 2017
A review of recent news, research, and treatment related to eczema.
Research in Review
Thursday, December 7, 2017
Peter Moffat talks about his experience with eczema and making awareness and education accessible.
Research in Review
Friday, November 3, 2017
New research data on atopic dermatitis (AD) recently was presented at the 26th European Academy of Dermatology and Venereology (EADV) Congress in Geneva, Switzerland.
Research in Review
Wednesday, November 1, 2017
These programs combine individual patient visits with a group hands-on experience, education, and peer support.